LIGHT	B-protein
,	O
a	O
TNF-like	B-protein
molecule	I-protein
,	O
costimulates	O
T	O
cell	O
proliferation	O
and	O
is	O
required	O
for	O
dendritic	B-cell_type
cell	I-cell_type
-mediated	O
allogeneic	O
T	O
cell	O
response	O
.	O

LIGHT	B-protein
is	O
a	O
recently	O
identified	O
member	O
of	O
the	O
TNF	B-protein
superfamily	I-protein
and	O
its	O
receptors	O
,	O
herpesvirus	B-protein
entry	I-protein
mediator	I-protein
and	O
lymphotoxin	B-protein
beta	I-protein
receptor	I-protein
,	O
are	O
found	O
in	O
T	B-cell_type
cells	I-cell_type
and	O
stromal	B-cell_type
cells	I-cell_type
.	O

In	O
this	O
study	O
,	O
we	O
demonstrate	O
that	O
LIGHT	B-protein
is	O
selectively	O
expressed	O
on	O
immature	B-cell_type
dendritic	I-cell_type
cells	I-cell_type
(	O
DCs	B-cell_type
)	O
generated	O
from	O
human	B-cell_type
PBMCs	I-cell_type
.	O

In	O
contrast	O
,	O
LIGHT	B-protein
is	O
not	O
detectable	O
in	O
DCs	B-cell_type
either	O
freshly	O
isolated	O
from	O
PBMCs	B-cell_type
or	O
rendered	O
mature	O
in	O
vitro	O
by	O
LPS	O
treatment	O
.	O

Blockade	O
of	O
LIGHT	B-protein
by	O
its	O
soluble	B-protein
receptors	I-protein
,	O
lymphotoxin	B-protein
beta	I-protein
receptor-Ig	I-protein
or	O
HVEM-Ig	B-protein
,	O
inhibits	O
the	O
induction	O
of	O
DC	B-cell_type
-mediated	O
primary	O
allogeneic	O
T	O
cell	O
response	O
.	O

Furthermore	O
,	O
engagement	O
of	O
LIGHT	B-protein
costimulates	O
human	O
T	O
cell	O
proliferation	O
,	O
amplifies	O
the	O
NF-kappaB	O
signaling	O
pathway	O
,	O
and	O
preferentially	O
induces	O
the	O
production	O
of	O
IFN-gamma	B-protein
,	O
but	O
not	O
IL-4	B-protein
,	O
in	O
the	O
presence	O
of	O
an	O
antigenic	O
signal	O
.	O

Our	O
results	O
suggest	O
that	O
LIGHT	B-protein
is	O
a	O
costimulatory	B-protein
molecule	I-protein
involved	O
in	O
DC	B-cell_type
-mediated	O
cellular	O
immune	O
responses	O
.	O

3	NULL
<	NULL
.	NULL

a	NULL
el	NULL
(	NULL
ap	NULL
)	NULL
D	NULL
3	NULL
Reporter	NULL
Cell	NULL
Lines	NULL
a	NULL
a	NULL
g	NULL
The	NULL
film	NULL
”	NULL
)	NULL
!	NULL

keeps	NULL
growing	NULL
Learn	NULL
more	NULL
Ka	NULL
meJournal	NULL
o	NULL
LIGHT	NULL
,	NULL
a	NULL
TNF-Like	NULL
Molecule	NULL
,	NULL
Costimulates	NULL
ﬁa	NULL
’	NULL
lmmunolo	NULL
gy	NULL
T	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Is	NULL
Required	NULL
for	NULL
Dendritic	NULL
Cell-Mediated	NULL
Allogeneic	NULL
T	NULL
Cell	NULL
Response	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

Koji	NULL
Tamada	NULL
,	NULL
Koji	NULL
Shimozaki	NULL
,	NULL
Andrei	NULL
I.	NULL
Chapoval	NULL
,	NULL
Yifan	NULL
Zhai	NULL
,	NULL
Jeffery	NULL
Su	NULL
,	NULL
Su-Fang	NULL
Chen	NULL
,	NULL
Shie-Liang	NULL
Hsieh	NULL
,	NULL
Shigekazu	NULL
Nagata	NULL
,	NULL
Jian	NULL
Ni	NULL
and	NULL
Lieping	NULL
Chen	NULL
J	NULL
Immunol	NULL
2000	NULL
;	NULL
164:4105-4110	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.164.8.4105	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/164/8/4105	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
37	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/164/8/4105	NULL
full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
LIGHT	NULL
,	NULL
a	NULL
TNF-Like	NULL
Molecule	NULL
,	NULL
Costimulates	NULL
T	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Is	NULL
Required	NULL
for	NULL
Dendritic	NULL
Cell-Mediated	NULL
Allogeneic	NULL
T	NULL
Cell	NULL
Response	NULL
'	NULL
Koji	NULL
Tamada	NULL
,	NULL
``	NULL
*	NULL
Koji	NULL
Shimozaki	NULL
,	NULL
``	NULL
*	NULL
'	NULL
Andrei	NULL
I.	NULL
Chapoval	NULL
,	NULL
*	NULL
Yifan	NULL
Zhai	NULL
,	NULL
*	NULL
Jeffery	NULL
Su	NULL
,	NULL
*	NULL
Su-Fang	NULL
Chen	NULL
,	NULL
*	NULL
Shie-Liang	NULL
Hsieh	NULL
,	NULL
``	NULL
Shigekazu	NULL
Nagata	NULL
,	NULL
``	NULL
Jian	NULL
Ni	NULL
,	NULL
*	NULL
and	NULL
Lieping	NULL
Chen**	NULL
LIGHT	NULL
is	NULL
a	NULL
recently	NULL
identified	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
superfamily	NULL
and	NULL
its	NULL
receptors	NULL
,	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
and	NULL
lymphotoxin	NULL
$	NULL
receptor	NULL
,	NULL
are	NULL
found	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
stromal	NULL
cells	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
LIGHT	NULL
is	NULL
selectively	NULL
expressed	NULL
on	NULL
immature	NULL
dendritic	NULL
cells	NULL
(	NULL
DCs	NULL
)	NULL
generated	NULL
from	NULL
human	NULL
PBMCs	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
LIGHT	NULL
is	NULL
not	NULL
detectable	NULL
in	NULL
DCs	NULL
either	NULL
freshly	NULL
isolated	NULL
from	NULL
PBMCs	NULL
or	NULL
rendered	NULL
mature	NULL
in	NULL
vitro	NULL
by	NULL
LPS	NULL
treatment	NULL
.	NULL

Blockade	NULL
of	NULL
LIGHT	NULL
by	NULL
its	NULL
soluble	NULL
receptors	NULL
,	NULL
lymphotoxin	NULL
B	NULL
receptor-Ig	NULL
or	NULL
HVEM-Ig	NULL
,	NULL
inhibits	NULL
the	NULL
induction	NULL
of	NULL
DC-mediated	NULL
primary	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Furthermore	NULL
,	NULL
engagement	NULL
of	NULL
LIGHT	NULL
costimulates	NULL
human	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
amplifies	NULL
the	NULL
NF-B	NULL
signaling	NULL
pathway	NULL
,	NULL
and	NULL
preferentially	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
antigenic	NULL
signal	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
LIGHT	NULL
is	NULL
a	NULL
costimulatory	NULL
molecule	NULL
involved	NULL
in	NULL
DC-mediated	NULL
cellular	NULL
immune	NULL
responses	NULL
.	NULL

-	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2000	NULL
,	NULL
164	NULL
;	NULL
4105-4110.	NULL
ccumulating	NULL
evidence	NULL
demonstrates	NULL
that	NULL
two	NULL
different	NULL
signals	NULL
are	NULL
necessary	NULL
for	NULL
the	NULL
optimal	NULL
activation	NULL
of	NULL
T	NULL
cell	NULL
response	NULL
,	NULL
a	NULL
first	NULL
signal	NULL
delivered	NULL
from	NULL
TCR	NULL
and	NULL
a	NULL
second	NULL
signal	NULL
from	NULL
costimulatory	NULL
molecules	NULL
such	NULL
as	NULL
CD80	NULL
and	NULL
CD86	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Costimulation	NULL
is	NULL
known	NULL
to	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
numerous	NULL
immune	NULL
responses	NULL
both	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

For	NULL
example	NULL
,	NULL
antigenic	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
costimulation	NULL
induces	NULL
an	NULL
unresponsive	NULL
state	NULL
known	NULL
as	NULL
anergy	NULL
(	NULL
2	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
activation	NULL
of	NULL
costimulatory	NULL
pathway	NULL
by	NULL
gene	NULL
transfer	NULL
(	NULL
3	NULL
)	NULL
or	NULL
an	NULL
agonistic	NULL
Ab	NULL
(	NULL
4	NULL
)	NULL
enhances	NULL
antitumor	NULL
immune	NULL
response	NULL
leading	NULL
to	NULL
regression	NULL
of	NULL
tu-mor	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
blockage	NULL
of	NULL
costimulatory	NULL
pathways	NULL
can	NULL
ameliorate	NULL
undesirable	NULL
immune	NULL
responses	NULL
such	NULL
as	NULL
autoimmunity	NULL
or	NULL
graft-versus-host	NULL
response	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
.	NULL

Costimulatory	NULL
molecules	NULL
B7-1	NULL
and	NULL
B7-2	NULL
are	NULL
expressed	NULL
on	NULL
professional	NULL
APCs	NULL
,	NULL
particularly	NULL
on	NULL
dendritic	NULL
cells	NULL
(	NULL
DCs	NULL
)	NULL
,	NULL
*	NULL
and	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
regulation	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
response	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
show	NULL
that	NULL
several	NULL
molecules	NULL
belonging	NULL
to	NULL
the	NULL
TNF	NULL
superfamily	NULL
function	NULL
as	NULL
costimulatory	NULL
molecules	NULL
for	NULL
the	NULL
in-duction	NULL
,	NULL
differentiation	NULL
,	NULL
and	NULL
survival	NULL
of	NULL
the	NULL
immune	NULL
cell	NULL
(	NULL
8	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
4-1BB	NULL
and	NULL
OX-40	NULL
can	NULL
costimulate	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
*Department	NULL
of	NULL
Immunology	NULL
,	NULL
Mayo	NULL
Graduate	NULL
and	NULL
Medical	NULL
Schools	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
;	NULL
*Department	NULL
of	NULL
Genetics	NULL
,	NULL
Osaka	NULL
University	NULL
Medical	NULL
School	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
;	NULL
*Human	NULL
Genome	NULL
Sciences	NULL
,	NULL
Inc.	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20850	NULL
;	NULL
and	NULL
``	NULL
Depart-ment	NULL
of	NULL
Microbiology	NULL
and	NULL
Immunology	NULL
,	NULL
National	NULL
Yang-Ming	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Taipei	NULL
,	NULL
Taiwan	NULL
,	NULL
Republic	NULL
of	NULL
China	NULL
Received	NULL
for	NULL
publication	NULL
December	NULL
9	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
February	NULL
9	NULL
,	NULL
2000	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
Mayo	NULL
Foundation	NULL
;	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
grants	NULL
;	NULL
the	NULL
grants-in-aid	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
Sports	NULL
,	NULL
and	NULL
Culture	NULL
in	NULL
Japan	NULL
;	NULL
and	NULL
Human	NULL
Genome	NULL
Sciences	NULL
,	NULL
Inc.	NULL
K.S	NULL
.	NULL

is	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
Ph.D.	NULL
student	NULL
fellowship	NULL
from	NULL
the	NULL
Japan	NULL
Society	NULL
for	NULL
the	NULL
Promotion	NULL
of	NULL
Science	NULL
.	NULL

2	NULL
K.T	NULL
.	NULL

and	NULL
K.S	NULL
.	NULL

share	NULL
first	NULL
authorship	NULL
.	NULL

°	NULL
Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Lieping	NULL
Chen	NULL
,	NULL
Department	NULL
of	NULL
Immunology	NULL
,	NULL
Mayo	NULL
Clinic	NULL
,	NULL
200	NULL
First	NULL
Street	NULL
SW	NULL
,	NULL
Rochester	NULL
,	NULL
MN	NULL
55905	NULL
.	NULL

E-mail	NULL
ad-dress	NULL
:	NULL
chen.lieping	NULL
@	NULL
mayo.edu	NULL
*	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
DC	NULL
,	NULL
dendritic	NULL
cell	NULL
;	NULL
HVEM	NULL
,	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
;	NULL
h	NULL
,	NULL
human	NULL
;	NULL
m	NULL
,	NULL
murine	NULL
;	NULL
LT	NULL
,	NULL
lymphotoxin	NULL
.	NULL

Copyright	NULL
©	NULL
2000	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
affect	NULL
the	NULL
differentiation	NULL
of	NULL
subsets	NULL
of	NULL
Th	NULL
cells	NULL
(	NULL
9	NULL
,	NULL
10	NULL
)	NULL
.	NULL

Administration	NULL
of	NULL
anti-4-1BB	NULL
mAbs	NULL
elicits	NULL
curative	NULL
antitumor	NULL
immune	NULL
responses	NULL
against	NULL
established	NULL
tumors	NULL
in	NULL
several	NULL
mouse	NULL
models	NULL
(	NULL
4	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
costimulatory	NULL
functions	NULL
of	NULL
the	NULL
TNF	NULL
superfamily	NULL
can	NULL
be	NULL
manipulated	NULL
toward	NULL
therapeutic	NULL
benefit	NULL
.	NULL

LIGHT	NULL
(	NULL
homologous	NULL
to	NULL
lymphotoxins	NULL
,	NULL
exhibits	NULL
inducible	NULL
expression	NULL
,	NULL
and	NULL
competes	NULL
with	NULL
HSV	NULL
glycoprotein	NULL
D	NULL
for	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
(	NULL
HVEM	NULL
)	NULL
,	NULL
a	NULL
receptor	NULL
expressed	NULL
by	NULL
T	NULL
lymphocytes	NULL
)	NULL
is	NULL
a	NULL
recently	NULL
identified	NULL
member	NULL
of	NULL
TNF	NULL
superfamily	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Several	NULL
studies	NULL
showed	NULL
that	NULL
MLR	NULL
can	NULL
be	NULL
enhanced	NULL
by	NULL
inclusion	NULL
of	NULL
soluble	NULL
LIGHT	NULL
(	NULL
12	NULL
)	NULL
and	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
neutralization	NULL
of	NULL
LIGHT	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
LIGHT	NULL
is	NULL
involved	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
effector	NULL
cells	NULL
and	NULL
precise	NULL
mechanisms	NULL
of	NULL
LIGHT	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
remain	NULL
unknown	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
study	NULL
the	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
human	NULL
DC	NULL
and	NULL
its	NULL
role	NULL
in	NULL
costimulation	NULL
of	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Fusion	NULL
proteins	NULL
and	NULL
Abs	NULL
To	NULL
prepare	NULL
human	NULL
(	NULL
b	NULL
)	NULL
LIGHT	NULL
as	NULL
a	NULL
soluble	NULL
protein	NULL
,	NULL
a	NULL
542-bp	NULL
fragment	NULL
of	NULL
extracellular	NULL
domain	NULL
of	NULL
hLIGHT	NULL
(	NULL
Q60-V	NULL
240	NULL
)	NULL
was	NULL
amplified	NULL
from	NULL
the	NULL
full-length	NULL
LIGHT	NULL
cDNA	NULL
clone	NULL
(	NULL
11	NULL
)	NULL
by	NULL
PCR	NULL
(	NULL
sense	NULL
primer	NULL
,	NULL
5-GCGGGATC	NULL
CCAGCTGCACTGGCGTCTAG-3	NULL
'	NULL
;	NULL
antisense	NULL
primer	NULL
,	NULL
CACCATGAAAGCCCCGA-3	NULL
'	NULL
)	NULL
.	NULL

After	NULL
digestion	NULL
with	NULL
BamHI	NULL
,	NULL
the	NULL
PCR	NULL
product	NULL
was	NULL
cloned	NULL
into	NULL
pC4CKB8-IgFc	NULL
vector	NULL
,	NULL
which	NULL
contains	NULL
CkB	NULL
8	NULL
signal	NULL
peptide	NULL
(	NULL
15	NULL
)	NULL
,	NULL
to	NULL
yield	NULL
a	NULL
construct	NULL
encoding	NULL
amino	NULL
acid	NULL
residues	NULL
Q60-V240	NULL
of	NULL
the	NULL
LIGHT	NULL
sequence	NULL
fused	NULL
at	NULL
the	NULL
C	NULL
terminus	NULL
with	NULL
the	NULL
234-residue	NULL
hinge	NULL
of	NULL
the	NULL
CH2	NULL
and	NULL
CH3	NULL
regions	NULL
of	NULL
hIgG1	NULL
(	NULL
16	NULL
)	NULL
.	NULL

The	NULL
construct	NULL
was	NULL
then	NULL
transfected	NULL
into	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
hLIGHT-Ig	NULL
fusion	NULL
protein	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
conditioned	NULL
media	NULL
by	NULL
a	NULL
Sepharose-Protein	NULL
A	NULL
affinity	NULL
column	NULL
.	NULL

Isolated	NULL
hLIGHT-Ig	NULL
was	NULL
greater	NULL
than	NULL
95	NULL
%	NULL
purity	NULL
,	NULL
and	NULL
LPS	NULL
content	NULL
was	NULL
less	NULL
than	NULL
0.1	NULL
ng/mg	NULL
of	NULL
purified	NULL
protein	NULL
according	NULL
to	NULL
Limulus	NULL
amebocyte	NULL
lysate	NULL
assays	NULL
(	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Production	NULL
and	NULL
preparation	NULL
of	NULL
hHVEM-Ig	NULL
(	NULL
17	NULL
)	NULL
and	NULL
human	NULL
lymphotoxin	NULL
B	NULL
receptor	NULL
(	NULL
hLTBR	NULL
)	NULL
-Ig	NULL
(	NULL
18	NULL
)	NULL
were	NULL
previously	NULL
described	NULL
.	NULL

hCTLA4Ig	NULL
was	NULL
constructed	NULL
following	NULL
the	NULL
protocol	NULL
described	NULL
previously	NULL
(	NULL
19	NULL
)	NULL
and	NULL
was	NULL
purified	NULL
from	NULL
the	NULL
culture	NULL
supernatant	NULL
of	NULL
Chinese	NULL
hamster	NULL
ovary	NULL
cells	NULL
by	NULL
a	NULL
Sepharose-Protein	NULL
A	NULL
affinity	NULL
column	NULL
.	NULL

A	NULL
similar	NULL
method	NULL
was	NULL
used	NULL
for	NULL
preparation	NULL
of	NULL
murine	NULL
(	NULL
m	NULL
)	NULL
4-1BB-Ig	NULL
.	NULL

Rabbit	NULL
anti-LIGHT	NULL
Ab	NULL
(	NULL
ML69	NULL
)	NULL
was	NULL
prepared	NULL
at	NULL
Cocalico	NULL
Biologicals	NULL
(	NULL
Reamstown	NULL
,	NULL
PA	NULL
)	NULL
by	NULL
immunizing	NULL
rabbits	NULL
with	NULL
a	NULL
keyhole	NULL
limpet	NULL
hemocy-anin-conjugated	NULL
synthetic	NULL
peptide	NULL
encoding	NULL
4	NULL
,	NULL
(	NULL
HLPDGGKG	NULL
0022-1767/00/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4106	NULL
SWEKLIQDQRSHQANC	NULL
)	NULL
(	NULL
20	NULL
)	NULL
.	NULL

The	NULL
antiserum	NULL
was	NULL
purified	NULL
with	NULL
a	NULL
column	NULL
to	NULL
which	NULL
the	NULL
LIGHT	NULL
peptide	NULL
had	NULL
been	NULL
conjugated	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
Ab	NULL
to	NULL
mouse	NULL
and	NULL
human	NULL
LIGHT	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
binding	NULL
of	NULL
recombinant	NULL
mouse	NULL
and	NULL
human	NULL
LIGHT	NULL
protein	NULL
in	NULL
ELISA	NULL
and	NULL
293	NULL
cells	NULL
transfected	NULL
to	NULL
express	NULL
LIGHT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Purified	NULL
mAb	NULL
to	NULL
human	NULL
CD3	NULL
(	NULL
HIT3a	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

T	NULL
cell	NULL
proliferation	NULL
assay	NULL
PBMCs	NULL
were	NULL
separated	NULL
from	NULL
healthy	NULL
donors	NULL
by	NULL
Ficoll-Hypaque	NULL
(	NULL
Pharma-cia	NULL
Biotech	NULL
,	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
)	NULL
density	NULL
gradient	NULL
centrifugation	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
complete	NULL
medium	NULL
consisting	NULL
of	NULL
RPMI	NULL
1640	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FBS	NULL
(	NULL
HyClone	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
25	NULL
mM	NULL
HEPES	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
G	NULL
,	NULL
and	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
sulfate	NULL
.	NULL

To	NULL
purify	NULL
T	NULL
cells	NULL
,	NULL
adherent	NULL
cells	NULL
were	NULL
first	NULL
eliminated	NULL
by	NULL
incubation	NULL
on	NULL
plastic	NULL
tissue	NULL
culture	NULL
plates	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
,	NULL
and	NULL
nonadherent	NULL
cells	NULL
were	NULL
collected	NULL
and	NULL
passed	NULL
through	NULL
nylon	NULL
wool	NULL
columns	NULL
(	NULL
Robbins	NULL
Scientific	NULL
,	NULL
Sunnyvale	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Purity	NULL
of	NULL
isolated	NULL
human	NULL
T	NULL
cells	NULL
was	NULL
>	NULL
85	NULL
%	NULL
.	NULL

DCs	NULL
were	NULL
generated	NULL
from	NULL
adherent	NULL
PBMCs	NULL
by	NULL
culture	NULL
in	NULL
the	NULL
complete	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
800	NULL
U/ml	NULL
GM-CSF	NULL
(	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
WA	NULL
)	NULL
and	NULL
500	NULL
U/ml	NULL
IL-4	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
for	NULL
7	NULL
days	NULL
,	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
21	NULL
)	NULL
.	NULL

For	NULL
induction	NULL
of	NULL
allogeneic	NULL
MLR	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
cocultured	NULL
with	NULL
40	NULL
Gy-irradiated	NULL
allogeneic	NULL
DCs	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
in	NULL
flat-bottom	NULL
96-well	NULL
microplates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
fusion	NULL
proteins	NULL
or	NULL
control	NULL
IgG1	NULL
(	NULL
hIgG1	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

For	NULL
anti-CD3	NULL
mAb-induced	NULL
T	NULL
cell	NULL
proliferation	NULL
assay	NULL
,	NULL
flat-bottom	NULL
96-well	NULL
microplates	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
the	NULL
indicated	NULL
doses	NULL
of	NULL
an	NULL
anti-CD3	NULL
mAb	NULL
diluted	NULL
in	NULL
50	NULL
ul	NULL
PBS	NULL
at	NULL
4°C	NULL
for	NULL
18	NULL
h.	NULL
After	NULL
washing	NULL
,	NULL
the	NULL
plates	NULL
were	NULL
further	NULL
coated	NULL
with	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
higG1	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
h	NULL
,	NULL
and	NULL
then	NULL
purified	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
.	NULL

In	NULL
all	NULL
proliferation	NULL
assays	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
for	NULL
72	NULL
h	NULL
,	NULL
and	NULL
[	NULL
°HJTdR	NULL
at	NULL
1	NULL
.Ci/well	NULL
was	NULL
added	NULL
during	NULL
the	NULL
last	NULL
15	NULL
h.	NULL
Incorporation	NULL
of	NULL
[	NULL
°HJTdR	NULL
was	NULL
counted	NULL
by	NULL
a	NULL
MicroBeta	NULL
TriLux	NULL
liquid	NULL
scintillation	NULL
counter	NULL
(	NULL
Wallac	NULL
,	NULL
Turku	NULL
,	NULL
Finland	NULL
)	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
of	NULL
DCs	NULL
Human	NULL
immature	NULL
DCs	NULL
were	NULL
generated	NULL
from	NULL
adherent	NULL
PBMCs	NULL
as	NULL
described	NULL
above	NULL
.	NULL

To	NULL
prepare	NULL
mature	NULL
activated	NULL
DCs	NULL
,	NULL
immature	NULL
DCs	NULL
were	NULL
further	NULL
incubated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LPS	NULL
(	NULL
1	NULL
pg/ml	NULL
;	NULL
Sigma	NULL
)	NULL
or	NULL
anti-human	NULL
CD40	NULL
mAb	NULL
(	NULL
clone	NULL
G28.5	NULL
at	NULL
5	NULL
ug/ml	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h.	NULL
Immature	NULL
or	NULL
mature	NULL
DCs	NULL
were	NULL
stained	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
either	NULL
2	NULL
ug	NULL
of	NULL
hHVEM-Ig	NULL
or	NULL
hLTBR-Ig	NULL
or	NULL
1	NULL
ug	NULL
of	NULL
anti-LIGHT	NULL
Ab	NULL
in	NULL
100	NULL
pl	NULL
of	NULL
PBS	NULL
supplemented	NULL
with	NULL
3	NULL
%	NULL
FBS	NULL
and	NULL
0.02	NULL
%	NULL
azide	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
and	NULL
further	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
with	NULL
either	NULL
FITC-conjugated	NULL
goat	NULL
anti-human	NULL
IgG	NULL
(	NULL
BioSource	NULL
,	NULL
Camarillo	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
FITC-conjugated	NULL
goat	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
Southern	NULL
Biotechnology	NULL
As-sociates	NULL
,	NULL
Birmingham	NULL
,	NULL
AL	NULL
)	NULL
.	NULL

DCs	NULL
were	NULL
also	NULL
stained	NULL
with	NULL
FITC-conjugated	NULL
anti-CD86	NULL
mAb	NULL
as	NULL
the	NULL
positive	NULL
control	NULL
.	NULL

Human	NULL
peripheral	NULL
blood	NULL
fresh	NULL
DCs	NULL
were	NULL
enriched	NULL
and	NULL
identified	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
22	NULL
)	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL

Briefly	NULL
,	NULL
T	NULL
,	NULL
B	NULL
,	NULL
and	NULL
NK	NULL
cells	NULL
and	NULL
macrophages	NULL
were	NULL
depleted	NULL
from	NULL
PBMCs	NULL
by	NULL
passing	NULL
through	NULL
a	NULL
magnetic	NULL
field	NULL
twice	NULL
after	NULL
staining	NULL
with	NULL
a	NULL
cocktail	NULL
of	NULL
FITC-conjugated	NULL
anti-CD3	NULL
,	NULL
-CD19	NULL
,	NULL
-CD16	NULL
,	NULL
and	NULL
-CD14	NULL
mAbs	NULL
and	NULL
then	NULL
with	NULL
anti-FITC	NULL
magnetic	NULL
beads	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

After	NULL
depletion	NULL
,	NULL
negatively	NULL
enriched	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
FITC-conjugated	NULL
anti-CD4	NULL
and	NULL
PE-conjugated	NULL
anti-HLA-DR	NULL
mAbs	NULL
.	NULL

A	NULL
subpopulation	NULL
,	NULL
which	NULL
represents	NULL
large	NULL
and	NULL
bright	NULL
cells	NULL
in	NULL
forward	NULL
and	NULL
side	NULL
scatters	NULL
and	NULL
is	NULL
equivalent	NULL
to	NULL
25	NULL
%	NULL
of	NULL
the	NULL
enriched	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
,	NULL
was	NULL
identified	NULL
to	NULL
express	NULL
CD4	NULL
and	NULL
HLA-DR	NULL
.	NULL

The	NULL
subpopulation	NULL
was	NULL
gated	NULL
and	NULL
analyzed	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
LIGHT	NULL
by	NULL
ML69	NULL
.	NULL

Fluorescence	NULL
was	NULL
analyzed	NULL
by	NULL
FACSCalibur	NULL
flow	NULL
cytometry	NULL
(	NULL
Becton	NULL
Dick-inson	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
with	NULL
CellQuest	NULL
software	NULL
(	NULL
Becton	NULL
Dickinson	NULL
)	NULL
.	NULL

All	NULL
mAbs	NULL
used	NULL
for	NULL
FACS	NULL
analysis	NULL
were	NULL
purchased	NULL
from	NULL
PharMingen	NULL
.	NULL

NF-KB	NULL
assay	NULL
The	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
determined	NULL
by	NULL
gel	NULL
shift	NULL
assay	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
23	NULL
)	NULL
but	NULL
with	NULL
modifications	NULL
.	NULL

Human	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
purified	NULL
from	NULL
PBMCs	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
plate	NULL
,	NULL
which	NULL
was	NULL
precoated	NULL
with	NULL
2	NULL
pg/ml	NULL
of	NULL
anti-CD3	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
soluble	NULL
hLIGHT	NULL
for	NULL
2	NULL
h.	NULL
Cells	NULL
were	NULL
collected	NULL
,	NULL
suspended	NULL
in	NULL
150	NULL
pl	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES-KOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
supplemented	NULL
by	NULL
protease	NULL
and	NULL
phosphatase	NULL
inhibitors	NULL
(	NULL
0.1	NULL
mM	NULL
Na	NULL
;	NULL
VO	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
1	NULL
mM	NULL
PMSF	NULL
,	NULL
2	NULL
pg/ml	NULL
aprotinin	NULL
,	NULL
2	NULL
ug/ml	NULL
pepstatin	NULL
A	NULL
,	NULL
and	NULL
2	NULL
pg/ml	NULL
leupeptin	NULL
)	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
adding	NULL
10	NULL
pl	NULL
of	NULL
10	NULL
%	NULL
Nonidet	NULL
P-40	NULL
.	NULL

Nuclei	NULL
were	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
suspended	NULL
in	NULL
25	NULL
pl	NULL
buffer	NULL
B	NULL
(	NULL
20	NULL
mM	NULL
HEPES-KOH	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
,	NULL
400	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
DTT	NULL
)	NULL
,	NULL
and	NULL
supplemented	NULL
with	NULL
the	NULL
phosphatase	NULL
and	NULL
protease	NULL
inhibitors	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
4°C	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
nuclei	NULL
were	NULL
centrifuged	NULL
for	NULL
10	NULL
min	NULL
at	NULL
15,000	NULL
X	NULL
g	NULL
,	NULL
and	NULL
the	NULL
supernatants	NULL
were	NULL
recovered	NULL
COSTIMULATORY	NULL
LIGAND	NULL
LIGHT	NULL
ON	NULL
HUMAN	NULL
DCs	NULL
as	NULL
nuclear	NULL
extracts	NULL
.	NULL

A	NULL
set	NULL
of	NULL
complementary	NULL
oligonucleotides	NULL
(	NULL
5'-TC	NULL
GAGAGTTGAGGGGGACTTTCCCAGGC-3	NULL
'	NULL
)	NULL
that	NULL
carry	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
were	NULL
annealed	NULL
and	NULL
end-labeled	NULL
with	NULL
5'-triphosphate	NULL
(	NULL
3,000	NULL
Ci/mmol	NULL
)	NULL
and	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
Escherichia	NULL
coli	NULL
DNA	NULL
polymerase	NULL
.	NULL

The	NULL
reaction	NULL
mixture	NULL
for	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
contained	NULL
20	NULL
mM	NULL
HEPES	NULL
buffer	NULL
(	NULL
pH	NULL
7.8	NULL
)	NULL
,	NULL
80	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
DTT	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
10	NULL
ug	NULL
of	NULL
the	NULL
nuclear	NULL
extracts	NULL
,	NULL
and	NULL
62.5	NULL
fmol	NULL
probe	NULL
DNA	NULL
(	NULL
132,000	NULL
cpm	NULL
)	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
17	NULL
pl	NULL
.	NULL

After	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
,	NULL
the	NULL
products	NULL
were	NULL
resolved	NULL
by	NULL
electrophore-sis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
in	NULL
0.25	NULL
X	NULL
TBE	NULL
buffer	NULL
.	NULL

Soluble	NULL
hLIGHT	NULL
was	NULL
produced	NULL
in	NULL
COS	NULL
cells	NULL
by	NULL
transfecting	NULL
with	NULL
pEF-BOS-EX	NULL
vector	NULL
(	NULL
24	NULL
)	NULL
inserted	NULL
with	NULL
full-length	NULL
hLIGHT	NULL
cDNA	NULL
(	NULL
11	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
supernatant	NULL
was	NULL
collected	NULL
at	NULL
72	NULL
h	NULL
after	NULL
transfection	NULL
and	NULL
used	NULL
as	NULL
the	NULL
soluble	NULL
hLIGHT	NULL
.	NULL

Cytokine	NULL
assay	NULL
by	NULL
ELISA	NULL
Human	NULL
purified	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
plate-coated	NULL
hLIGHT	NULL
Ig	NULL
(	NULL
10	NULL
ug/ml	NULL
!	NULL
)	NULL

or	NULL
control	NULL
higG1	NULL
(	NULL
10	NULL
pg/ml	NULL
!	NULL
)	NULL

in	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
doses	NULL
of	NULL
plate-coated	NULL
anti-CD3	NULL
mAb	NULL
.	NULL

After	NULL
2	NULL
,	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
5	NULL
days	NULL
,	NULL
the	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
the	NULL
cytokine	NULL
concentration	NULL
was	NULL
assessed	NULL
by	NULL
sandwich	NULL
ELISA	NULL
for	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
according	NULL
to	NULL
the	NULL
manufacture	NULL
's	NULL
instructions	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

Results	NULL
Selective	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
human	NULL
immature	NULL
DCs	NULL
The	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
human	NULL
DCs	NULL
during	NULL
differentiation	NULL
was	NULL
determined	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Immature	NULL
human	NULL
DCs	NULL
were	NULL
generated	NULL
from	NULL
adherent	NULL
PBMCs	NULL
of	NULL
healthy	NULL
donors	NULL
by	NULL
standard	NULL
method	NULL
(	NULL
21	NULL
)	NULL
.	NULL

After	NULL
7	NULL
days	NULL
of	NULL
culture	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
GM-CSF	NULL
+	NULL
IL-4	NULL
,	NULL
contaminated	NULL
macrophages	NULL
(	NULL
CD14	NULL
*	NULL
)	NULL
and	NULL
B	NULL
cells	NULL
(	NULL
CD19	NULL
*	NULL
)	NULL
were	NULL
typically	NULL
less	NULL
than	NULL
6	NULL
and	NULL
4	NULL
%	NULL
,	NULL
respectively	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Immature	NULL
DCs	NULL
exhibited	NULL
a	NULL
low-level	NULL
expression	NULL
of	NULL
CD86	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
and	NULL
few	NULL
dendrites	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Staining	NULL
of	NULL
immature	NULL
DCs	NULL
with	NULL
a	NULL
soluble	NULL
receptor	NULL
of	NULL
LIGHT	NULL
,	NULL
hLTBR-Ig	NULL
,	NULL
and	NULL
hHVEM-Ig	NULL
demonstrated	NULL
significant	NULL
binding	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

We	NULL
also	NULL
stained	NULL
cells	NULL
with	NULL
an	NULL
anti-LIGHT	NULL
Ab	NULL
,	NULL
ML69	NULL
,	NULL
specific	NULL
for	NULL
both	NULL
human	NULL
and	NULL
mLIGHT	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
significant	NULL
staining	NULL
with	NULL
ML6G9	NULL
was	NULL
demonstrated	NULL
on	NULL
immature	NULL
DCs	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
center	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
mature	NULL
DCs	NULL
was	NULL
examined	NULL
after	NULL
further	NULL
stimulation	NULL
of	NULL
immature	NULL
DCs	NULL
with	NULL
LPS	NULL
or	NULL
anti-CD40	NULL
mAb	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
,	NULL
the	NULL
expression	NULL
level	NULL
of	NULL
CD86	NULL
on	NULL
activated	NULL
DCs	NULL
increased	NULL
significantly	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
LIGHT	NULL
was	NULL
remarkably	NULL
down-regulated	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
mature	NULL
DCs	NULL
after	NULL
exposure	NULL
to	NULL
LPS	NULL
or	NULL
anti-CD40	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

We	NULL
further	NULL
investigated	NULL
the	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
freshly	NULL
isolated	NULL
DCs	NULL
.	NULL

CD3	NULL
*	NULL
,	NULL
CD14*	NULL
,	NULL
CD16	NULL
*	NULL
,	NULL
and	NULL
CD19	NULL
*	NULL
cells	NULL
were	NULL
depleted	NULL
from	NULL
PBMCs	NULL
of	NULL
healthy	NULL
donors	NULL
with	NULL
magnetic	NULL
beads	NULL
and	NULL
subsequently	NULL
were	NULL
stained	NULL
with	NULL
mAbs	NULL
to	NULL
HLA-DR	NULL
and	NULL
CD4	NULL
(	NULL
22	NULL
,	NULL
27	NULL
,	NULL
28	NULL
)	NULL
.	NULL

An	NULL
HLA-DR	NULL
*CD4*	NULL
subset	NULL
of	NULL
large	NULL
and	NULL
bright	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
after	NULL
depletion	NULL
was	NULL
identified	NULL
as	NULL
containing	NULL
peripheral	NULL
blood	NULL
DCs	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
center	NULL
panel	NULL
)	NULL
.	NULL

Anti-LIGHT	NULL
Ab	NULL
ML69	NULL
did	NULL
not	NULL
stain	NULL
this	NULL
subset	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
LIGHT	NULL
is	NULL
not	NULL
expressed	NULL
on	NULL
peripheral	NULL
blood	NULL
DCs	NULL
.	NULL

Inhibition	NULL
of	NULL
DC-induced	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
by	NULL
blockade	NULL
of	NULL
LIGHT	NULL
To	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
LIGHT	NULL
in	NULL
DC-induced	NULL
primary	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
,	NULL
purified	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
allogeneic	NULL
DCs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
hHVEM-Ig	NULL
or	NULL
hLTBR-Ig	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
DCs	NULL
induce	NULL
a	NULL
high	NULL
level	NULL
of	NULL
proliferation	NULL
of	NULL
allogeneic	NULL
T	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
inclusion	NULL
of	NULL
hHVEM-Ig	NULL
or	NULL
hLTBR-Ig	NULL
significantly	NULL
inhibited	NULL
the	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
in	NULL
a	NULL
degree	NULL
similar	NULL
to	NULL
that	NULL
in	NULL
hCTLA4Ig	NULL
,	NULL
a	NULL
soluble	NULL
receptor	NULL
for	NULL
B7	NULL
molecules	NULL
(	NULL
19	NULL
)	NULL
,	NULL
whereas	NULL
neither	NULL
hIgG	NULL
nor	NULL
m4-1BB-Ig	NULL
control	NULL
protein	NULL
exhibited	NULL
inhibitory	NULL
ef-fects	NULL
.	NULL

Also	NULL
,	NULL
both	NULL
hHVEM-Ig	NULL
and	NULL
hLTBR-Ig	NULL
saturate	NULL
at	NULL
concentrations	NULL
of	NULL
0.625-1.25	NULL
ug/ml	NULL
,	NULL
and	NULL
the	NULL
inhibitory	NULL
effect	NULL
plateaus	NULL
at	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
FIGURE	NULL
1	NULL
.	NULL

LIGHT	NULL
is	NULL
expressed	NULL
on	NULL
immature	NULL
but	NULL
not	NULL
on	NULL
mature	NULL
DCs	NULL
and	NULL
peripheral	NULL
blood	NULL
DCs	NULL
.	NULL

A	NULL
,	NULL
Hu-	NULL
7	NULL
man	NULL
immature	NULL
DCs	NULL
were	NULL
prepared	NULL
from	NULL
adherent	NULL
PB	NULL
MCs	NULL
by	NULL
culture	NULL
with	NULL
800	NULL
U/ml	NULL
GM-CSF	NULL
and	NULL
500	NULL
U/ml	NULL
IL-4	NULL
for	NULL
7	NULL
days	NULL
.	NULL

B	NULL
,	NULL
Mature	NULL
DCs	NULL
were	NULL
generated	NULL
from	NULL
the	NULL
immature	NULL
DCs	NULL
by	NULL
the	NULL
stimulation	NULL
with	NULL
1	NULL
pg/ml	NULL
LPS	NULL
or	NULL
5	NULL
pg/ml	NULL
anti-CD40	NULL
mAb	NULL
for	NULL
an	NULL
additional	NULL
24	NULL
h.	NULL
These	NULL
DCs	NULL
were	NULL
incubated	NULL
with	NULL
either	NULL
hHVEM-	NULL
Ig	NULL
,	NULL
LTBR-Ig	NULL
,	NULL
or	NULL
rabbit	NULL
anti-LIGHT	NULL
Ab	NULL
(	NULL
ML69	NULL
)	NULL
for	NULL
30	NULL
B	NULL
4107	NULL
--	NULL
--	NULL
control	NULL
hig	NULL
--	NULL
hHvemHig|	NULL
i	NULL
_	NULL
;	NULL
1	NULL
.	NULL

--	NULL
hLTBR-Ig	NULL
10	NULL
:	NULL
4	NULL
A	NULL
ood	NULL
_	NULL
w	NULL
'	NULL
)	NULL
0	NULL
io	NULL
0	NULL
#	NULL
0	NULL
as	NULL
oat	NULL
0	NULL
ad	NULL
0	NULL
ad	NULL
0	NULL
as	NULL
0	NULL
ant	NULL
anti-LIGHT	NULL
--	NULL
»	NULL
»	NULL
anti-CD86	NULL
--	NULL
»	NULL
min	NULL
at	NULL
4°C	NULL
and	NULL
subsequently	NULL
were	NULL
stained	NULL
with	NULL
FITC-conjugated	NULL
anti-human	NULL
IgG	NULL
or	NULL
FITC-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

DCs	NULL
were	NULL
also	NULL
stained	NULL
with	NULL
}	NULL
FITC-conjugated	NULL
anti-CD86	NULL
mAb	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

Normal	NULL
human	NULL
IgG	NULL
or	NULL
rabbit	NULL
IgG	NULL
was	NULL
used	NULL
as	NULL
control	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
.	NULL

C	NULL
,	NULL
For	NULL
analysis	NULL
of	NULL
peripheral	NULL
blood	NULL
DCs	NULL
,	NULL
PBMCs	NULL
LPS	NULL
anti-CD40	NULL
LPS	NULL
of	NULL
healthy	NULL
donors	NULL
were	NULL
depleted	NULL
with	NULL
CD3-	NULL
,	NULL
CD14-	NULL
,	NULL
10°	NULL
10	NULL
)	NULL
CD16-	NULL
,	NULL
and	NULL
CD19-expressing	NULL
cells	NULL
by	NULL
magnetic	NULL
cell	NULL
separation	NULL
system	NULL
.	NULL

Among	NULL
the	NULL
resulting	NULL
lineage	NULL
Ag-negative	NULL
cells	NULL
,	NULL
a	NULL
subpopulation	NULL
representing	NULL
large	NULL
and	NULL
C	NULL
bright	NULL
cells	NULL
in	NULL
forward	NULL
and	NULL
side	NULL
scatters	NULL
was	NULL
gated	NULL
as	NULL
R1	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
R1	NULL
population	NULL
was	NULL
analyzed	NULL
by	NULL
staining	NULL
with	NULL
FITC-conjugated	NULL
CD4	NULL
and	NULL
PE-conjugated	NULL
HLA-DR	NULL
mAbs	NULL
(	NULL
center	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LIGHT	NULL
on	NULL
R1	NULL
population	NULL
was	NULL
also	NULL
examined	NULL
with	NULL
ML69	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
or	NULL
control	NULL
rabbit	NULL
IgG	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
and	NULL
then	NULL
with	NULL
FITC-conjugated	NULL
anti-rabbit	NULL
IgG	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

50-65	NULL
%	NULL
,	NULL
suggesting	NULL
that	NULL
LIGHT	NULL
is	NULL
not	NULL
the	NULL
only	NULL
factor	NULL
determining	NULL
the	NULL
response	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
indicate	NULL
that	NULL
LIGHT	NULL
is	NULL
required	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
for	NULL
DC-induced	NULL
primary	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Costimulatory	NULL
activity	NULL
of	NULL
LIGHT	NULL
in	NULL
T	NULL
cell	NULL
response	NULL
induced	NULL
by	NULL
anti-CD3	NULL
mAb	NULL
B7-1	NULL
and	NULL
B7-2	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
the	NULL
key	NULL
costimulators	NULL
for	NULL
DC-mediated	NULL
T	NULL
cell	NULL
response	NULL
(	NULL
7	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
LIGHT	NULL
can	NULL
act	NULL
as	NULL
a	NULL
T	NULL
cell	NULL
costimulator	NULL
,	NULL
hLIGHT-Ig	NULL
was	NULL
immobilized	NULL
on	NULL
a	NULL
96-well	NULL
plate	NULL
to	NULL
stimulate	NULL
purified	NULL
naive	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
as	NULL
a	NULL
mimicking	NULL
antigenic	NULL
signal	NULL
.	NULL

Immobilized	NULL
hLIGHT-Ig	NULL
significantly	NULL
enhanced	NULL
the	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
in	NULL
the	NULL
presence	NULL
,	NULL
but	NULL
not	NULL
in	NULL
the	NULL
absence	NULL
,	NULL
of	NULL
anti-CD3	NULL
.	NULL

Maximal	NULL
effect	NULL
of	NULL
LIGHT	NULL
on	NULL
the	NULL
stimulation	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
shown	NULL
when	NULL
anti-CD3	NULL
was	NULL
used	NULL
in	NULL
suboptimal	NULL
concentrations	NULL
(	NULL
range	NULL
,	NULL
0.02-0.08	NULL
pg/m	NULL
!	NULL
)	NULL

(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
,	NULL
demonstrating	NULL
that	NULL
hLIGHT-Ig	NULL
costimulates	NULL
T	NULL
cell	NULL
growth	NULL
when	NULL
engagement	NULL
of	NULL
TCR	NULL
occurs	NULL
.	NULL

A	NULL
significant	NULL
costimulatory	NULL
effect	NULL
could	NULL
be	NULL
detected	NULL
using	NULL
as	NULL
little	NULL
as	NULL
2.5	NULL
ug/ml	NULL
hLIGHT-Ig	NULL
,	NULL
and	NULL
increased	NULL
concentration	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
can	NULL
further	NULL
stimulate	NULL
T	NULL
cell	NULL
growth	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Costimulatory	NULL
effects	NULL
of	NULL
cross-linked	NULL
hLIGHT-Ig	NULL
can	NULL
be	NULL
completely	NULL
abrogated	NULL
by	NULL
soluble	NULL
hHVEM-Ig	NULL
or	NULL
hLTBR-Ig	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
,	NULL
but	NULL
not	NULL
by	NULL
the	NULL
control	NULL
higG	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
demonstrate	NULL
that	NULL
LIGHT	NULL
can	NULL
serve	NULL
as	NULL
a	NULL
costimulatory	NULL
molecule	NULL
for	NULL
stimulation	NULL
of	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

NF-KB	NULL
activation	NULL
on	NULL
T	NULL
cells	NULL
by	NULL
LIGHT	NULL
costimulation	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
and	NULL
translocation	NULL
is	NULL
a	NULL
crucial	NULL
event	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
LIGHT	NULL
can	NULL
costimulate	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
to	NULL
directly	NULL
detect	NULL
NF-B	NULL
translocation	NULL
in	NULL
nuclear	NULL
extracts	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
was	NULL
detectable	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
anti-CD3	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
LIGHT	NULL
protein	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
alone	NULL
.	NULL

However	NULL
,	NULL
highest	NULL
levels	NULL
of	NULL
NF-KB	NULL
activity	NULL
can	NULL
be	NULL
found	NULL
in	NULL
T	NULL
cells	NULL
stimulated	NULL
by	NULL
a	NULL
combination	NULL
of	NULL
anti-CD3	NULL
and	NULL
v	NULL
102	NULL
anti-LIGHT	NULL
--	NULL
»	NULL
»	NULL
FSC	NULL
--	NULL
r	NULL
.	NULL

h	NULL
18	NULL
0	NULL
aot	NULL
ao	NULL
_	NULL
aol	NULL
_	NULL
an	NULL
_	NULL
ao	NULL
_	NULL
ao	NULL
``	NULL
anti-LIGHT	NULL
--	NULL
p	NULL
»	NULL
anti-CD86	NULL
--	NULL
»	NULL
#	NULL
a	NULL
x	NULL
r	NULL
.	NULL

r	NULL
10	NULL
is	NULL
'	NULL
aot	NULL
_	NULL
an	NULL
_	NULL
s	NULL
®	NULL
anti-LIGHT	NULL
--	NULL
»	NULL
0	NULL
4	NULL
--	NULL
HLA-DR	NULL
--	NULL
»	NULL
LIGHT	NULL
protein	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
assay	NULL
is	NULL
NF-	NULL
«	NULL
B	NULL
binding-specific	NULL
because	NULL
inclusion	NULL
of	NULL
an	NULL
unlabeled	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
site	NULL
can	NULL
inhibit	NULL
the	NULL
binding	NULL
of	NULL
labeled	NULL
probes	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Our	NULL
result	NULL
indicate	NULL
that	NULL
LIGHT	NULL
can	NULL
costimulate	NULL
NF-KB	NULL
activation	NULL
and	NULL
translocation	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Preferential	NULL
induction	NULL
of	NULL
IFN-y	NULL
secretion	NULL
by	NULL
LIGHT	NULL
costimulation	NULL
Secretion	NULL
of	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
from	NULL
T	NULL
cells	NULL
after	NULL
LIGHT	NULL
costimulation	NULL
was	NULL
determined	NULL
by	NULL
specific	NULL
sandwich	NULL
ELISA	NULL
.	NULL

The	NULL
production	NULL
of	NULL
IFN-y	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
was	NULL
significantly	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
both	NULL
anti-CD3	NULL
and	NULL
hLIGHT	NULL
-Ig	NULL
in	NULL
comparison	NULL
to	NULL
anti-CD3	NULL
alone	NULL
or	NULL
anti-CD3	NULL
with	NULL
control	NULL
higG	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
.	NULL

Supernatant	NULL
from	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
hLIGHT-Ig	NULL
&	NULL
17.5	NULL
2	NULL
x	NULL
€	NULL
15	NULL
I	NULL
12.5	NULL
-	NULL
-L-	NULL
control	NULL
hlg	NULL
§	NULL
~	NULL
-O-	NULL
m4-1BB-lg	NULL
80	NULL
a40-	NULL
-B-	NULL
_	NULL
hHVEM-lg	NULL
o	NULL
8	NULL
--	NULL
hLTBR-1g	NULL
g	NULL
7.54	NULL
-ik-	NULL
_	NULL
hCTLA4-1g	NULL
$	NULL
0	NULL
5	NULL
I	NULL
®	NULL
25	NULL
u	NULL
T	NULL
T	NULL
T	NULL
T	NULL
0	NULL
0.6825	NULL
1.25	NULL
2.50	NULL
5	NULL
(	NULL
ug/ml	NULL
)	NULL
FIGURE	NULL
2	NULL
.	NULL

LIGHT	NULL
costimulation	NULL
is	NULL
required	NULL
for	NULL
DC-induced	NULL
allogeneic	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Purified	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
cocultured	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
with	NULL
40	NULL
Gy-irradiated	NULL
allogeneic	NULL
DCs	NULL
at	NULL
2	NULL
X	NULL
10°	NULL
cells/ml	NULL
in	NULL
96-well	NULL
flat-bottom	NULL
microplates	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
indicated	NULL
doses	NULL
of	NULL
soluble	NULL
control	NULL
hIgG	NULL
,	NULL
hHVEM-Ig	NULL
,	NULL
hLTBR-Ig	NULL
,	NULL
hCTLA4-Ig	NULL
,	NULL
or	NULL
m4-1BB-Ig	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
incubated	NULL
for	NULL
72	NULL
h	NULL
,	NULL
and	NULL
the	NULL
proliferative	NULL
responses	NULL
of	NULL
the	NULL
T	NULL
cells	NULL
were	NULL
monitored	NULL
by	NULL
[	NULL
°H	NULL
]	NULL
JTdR	NULL
incorporation	NULL
during	NULL
the	NULL
last	NULL
15	NULL
h.	NULL
The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4108	NULL
COSTIMULATORY	NULL
LIGAND	NULL
LIGHT	NULL
ON	NULL
HUMAN	NULL
DCs	NULL
A	NULL
-L-	NULL
no	NULL
coating	NULL
B	NULL
-	NULL
@	NULL
-	NULL
hLIGHT-lg	NULL
-O-	NULL
control	NULL
hig	NULL
_s	NULL
ou	NULL
FIGURE	NULL
3	NULL
.	NULL

Interaction	NULL
of	NULL
LIGHT	NULL
and	NULL
its	NULL
receptor	NULL
costimulates	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

Purified	NULL
human	NULL
T	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
for	NULL
72	NULL
h	NULL
in	NULL
96-well	NULL
flat-bottom	NULL
micro-plates	NULL
.	NULL

The	NULL
plates	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
indicated	NULL
doses	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
at	NULL
4°C	NULL
for	NULL
18	NULL
h.	NULL
After	NULL
washing	NULL
,	NULL
indicated	NULL
fusion	NULL
proteins	NULL
were	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
and	NULL
further	NULL
coated	NULL
at	NULL
37°C	NULL
for	NULL
4	NULL
h.	NULL
The	NULL
plates	NULL
were	NULL
washed	NULL
after	NULL
secondary	NULL
coating	NULL
,	NULL
and	NULL
purified	NULL
T	NULL
cells	NULL
were	NULL
added	NULL
to	NULL
the	NULL
wells	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
proliferative	NULL
re-	NULL
0	NULL
sponse	NULL
of	NULL
T	NULL
cells	NULL
was	NULL
monitored	NULL
by	NULL
[	NULL
°HJTdR	NULL
incorporation	NULL
during	NULL
the	NULL
last	NULL
15	NULL
h	NULL
of	NULL
72-h	NULL
cul-	NULL
ture	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
C	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

A	NULL
,	NULL
The	NULL
plates	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
indicated	NULL
doses	NULL
of	NULL
anti-CD3	NULL
mAb	NULL
and	NULL
then	NULL
further	NULL
coated	NULL
with	NULL
20	NULL
ug/ml	NULL
of	NULL
aa	NULL
=	NULL
}	NULL
&	NULL
n	NULL
3H-TdR	NULL
incorporation	NULL
(	NULL
cpm	NULL
x10-4	NULL
)	NULL
0	NULL
0.05	NULL
Anti-CD3	NULL
mAb	NULL
(	NULL
ug/ml	NULL
)	NULL
anti-CD3	NULL
immobilized	NULL
fusion	NULL
protein	NULL
protein	NULL
B	NULL
hLIGHT-1g	NULL
[	NULL
]	NULL
control	NULL
hig	NULL
12.5	NULL
3	NULL
o	NULL
x	NULL
z	NULL
10	NULL
a	NULL
<	NULL
§	NULL
157	NULL
FS	NULL
fall	NULL
a	NULL
-	NULL
57	NULL
O	NULL
[	NULL
3	NULL
G	NULL
2	NULL
25-I	NULL
&	NULL
O	NULL
0.1	NULL
0.15	NULL
0.2	NULL
0	NULL
1.250	NULL
250	NULL
50	NULL
100	NULL
20	NULL
protein	NULL
(	NULL
ug/m	NULL
!	NULL

1	NULL
)	NULL
soluble	NULL
fusion	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
hIgG	NULL
.	NULL

B	NULL
,	NULL
The	NULL
plates	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
a	NULL
suboptimal	NULL
dose	NULL
of	NULL
an	NULL
+	NULL
anti-CD3	NULL
mAb	NULL
(	NULL
0.05	NULL
pg/ml	NULL
)	NULL
and	NULL
then	NULL
further	NULL
coated	NULL
with	NULL
indicated	NULL
doses	NULL
of	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
hIgG	NULL
.	NULL

C	NULL
,	NULL
The	NULL
plates	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
0.05	NULL
ug/ml	NULL
of	NULL
an	NULL
anti-CD3	NULL
mAb	NULL
and	NULL
then	NULL
coated	NULL
with	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
hIgG	NULL
at	NULL
20	NULL
pug/tol	NULL
.	NULL

After	NULL
washing	NULL
,	NULL
hHVEM-Ig	NULL
,	NULL
hLTBR-Ig	NULL
,	NULL
or	NULL
higG	NULL
at	NULL
5	NULL
ug/ml	NULL
was	NULL
added	NULL
to	NULL
the	NULL
culture	NULL
+	NULL
together	NULL
with	NULL
purified	NULL
T	NULL
cells	NULL
.	NULL

+	NULL
hLIGHT-Ig	NULL
alone	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
anti-CD3	NULL
did	NULL
not	NULL
have	NULL
detectable	NULL
IFN-y	NULL
production	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
kinetics	NULL
of	NULL
cytokine	NULL
secretion	NULL
in	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
LIGHT	NULL
costimulation	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5B	NULL
,	NULL
sustained	NULL
enhancement	NULL
of	NULL
IFN-y	NULL
production	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
supernatants	NULL
of	NULL
T	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-CD3	NULL
and	NULL
hLIGHT-Ig	NULL
,	NULL
whereas	NULL
no	NULL
significant	NULL
increase	NULL
of	NULL
IL-4	NULL
production	NULL
was	NULL
observed	NULL
during	NULL
the	NULL
culture	NULL
for	NULL
up	NULL
to	NULL
5	NULL
days	NULL
.	NULL

Therefore	NULL
,	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIGURE	NULL
4	NULL
.	NULL

Activation	NULL
of	NULL
NF-KB	NULL
transcription	NULL
factor	NULL
by	NULL
LIGHT	NULL
stim-ulation	NULL
.	NULL

Human	NULL
T	NULL
cells	NULL
were	NULL
left	NULL
unstimulated	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
at	NULL
37°C	NULL
for	NULL
2	NULL
h	NULL
with	NULL
LIGHT	NULL
protein	NULL
alone	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
anti-CD3	NULL
alone	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
or	NULL
both	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
extracts	NULL
(	NULL
10	NULL
ug	NULL
protein	NULL
)	NULL
were	NULL
subjected	NULL
to	NULL
the	NULL
gel	NULL
shift	NULL
assay	NULL
with	NULL
a	NULL
*°P-labeled	NULL
NF-KB	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

Lanes	NULL
5	NULL
and	NULL
6	NULL
,	NULL
Gel	NULL
shift	NULL
assay	NULL
with	NULL
the	NULL
nuclear	NULL
extracts	NULL
used	NULL
in	NULL
lane	NULL
2	NULL
(	NULL
stimulated	NULL
by	NULL
hLIGHT	NULL
and	NULL
CD3	NULL
)	NULL
was	NULL
conducted	NULL
with	NULL
a	NULL
5-	NULL
and	NULL
50-fold	NULL
excess	NULL
of	NULL
the	NULL
competitor	NULL
unlabeled	NULL
oligonucleotide	NULL
,	NULL
respectively	NULL
.	NULL

control	NULL
hig	NULL
+	NULL
hLIGHT-1g	NULL
+	NULL
hLIGHT-Ig	NULL
RLIGHT-1g	NULL
hHVEM-Ig	NULL
hLTBR-Ig	NULL
control	NULL
hig	NULL
0	NULL
5	NULL
10	NULL
15	NULL
3H-TdR	NULL
incorporation	NULL
(	NULL
cpm	NULL
x10-4	NULL
)	NULL
these	NULL
results	NULL
suggest	NULL
that	NULL
LIGHT	NULL
costimulation	NULL
preferentially	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
LIGHT	NULL
,	NULL
a	NULL
TNF-like	NULL
molecule	NULL
,	NULL
is	NULL
a	NULL
novel	NULL
costimulatory	NULL
molecule	NULL
for	NULL
human	NULL
naive	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
and	NULL
produce	NULL
IFN-y	NULL
.	NULL

LIGHT	NULL
is	NULL
expressed	NULL
on	NULL
human	NULL
immature	NULL
DC	NULL
and	NULL
is	NULL
required	NULL
to	NULL
initiate	NULL
primary	NULL
allogeneic	NULL
T	NULL
cell	NULL
responses	NULL
induced	NULL
by	NULL
DC	NULL
.	NULL

Our	NULL
studies	NULL
thus	NULL
suggest	NULL
that	NULL
LIGHT	NULL
costimulation	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
.	NULL

It	NULL
is	NULL
generally	NULL
believed	NULL
that	NULL
adherent	NULL
PBMCs	NULL
or	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
give	NULL
rise	NULL
to	NULL
immature	NULL
myeloid	NULL
DCs	NULL
via	NULL
the	NULL
culture	NULL
with	NULL
GM-CSF	NULL
and	NULL
IL-4	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Further	NULL
maturation	NULL
can	NULL
be	NULL
driven	NULL
by	NULL
exposure	NULL
to	NULL
bacterial	NULL
endotoxin	NULL
or	NULL
CD40	NULL
ligand	NULL
(	NULL
25	NULL
,	NULL
26	NULL
)	NULL
.	NULL

Accompanied	NULL
with	NULL
their	NULL
maturation	NULL
,	NULL
Ag	NULL
uptake/processing	NULL
functions	NULL
of	NULL
DCs	NULL
reduce	NULL
,	NULL
whereas	NULL
their	NULL
capacities	NULL
to	NULL
stimulate	NULL
T	NULL
cell	NULL
responses	NULL
in-crease	NULL
.	NULL

This	NULL
shift	NULL
of	NULL
the	NULL
function	NULL
is	NULL
at	NULL
least	NULL
partially	NULL
due	NULL
to	NULL
up-regulation	NULL
of	NULL
costimulatory	NULL
molecules	NULL
(	NULL
7	NULL
)	NULL
.	NULL

Consistently	NULL
with	NULL
this	NULL
observation	NULL
,	NULL
CD86	NULL
expression	NULL
was	NULL
up-regulated	NULL
by	NULL
LPS	NULL
on	NULL
mature	NULL
DCs	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
LIGHT	NULL
decreases	NULL
during	NULL
the	NULL
maturation	NULL
of	NULL
DCs	NULL
in	NULL
our	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
down-regulation	NULL
of	NULL
LIGHT	NULL
on	NULL
mature	NULL
DCs	NULL
is	NULL
due	NULL
to	NULL
a	NULL
cleavage	NULL
of	NULL
membrane-bound	NULL
form	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
the	NULL
molecules	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
,	NULL
such	NULL
as	NULL
TNF-a	NULL
,	NULL
Fas	NULL
ligand	NULL
,	NULL
and	NULL
CD40	NULL
ligand	NULL
,	NULL
are	NULL
known	NULL
to	NULL
be	NULL
cleaved	NULL
by	NULL
matrix	NULL
metalloprotein-ases	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

In	NULL
these	NULL
cases	NULL
,	NULL
cleaved	NULL
molecules	NULL
remain	NULL
functional	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
IFN-y	NULL
5000	NULL
4000	NULL
a	NULL
3000	NULL
[	NULL
J	NULL
none	NULL
€	NULL
control	NULL
Ig	NULL
E	NULL
2000	NULL
B	NULL
hLIGHT-g	NULL
1000	NULL
0	NULL
40	NULL
80	NULL
anti-CD3	NULL
(	NULL
ng/ml	NULL
)	NULL
anti-CD3	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

B	NULL
IFN-y	NULL
IL-4	NULL
1000	NULL
500	NULL
400	NULL
750	NULL
<	NULL
€	NULL
300	NULL
[	NULL
J	NULL
control	NULL
Ig	NULL
£	NULL
500	NULL
o	NULL
©	NULL
hLIGHT-E	NULL
&	NULL
200	NULL
9	NULL
250	NULL
100	NULL
culture	NULL
days	NULL
culture	NULL
days	NULL
FIGURE	NULL
5	NULL
.	NULL

LIGHT	NULL
costimulates	NULL
T	NULL
cells	NULL
to	NULL
produce	NULL
IFN-y	NULL
but	NULL
not	NULL
IL-4	NULL
.	NULL

Purified	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
the	NULL
96-well	NULL
microplates	NULL
,	NULL
which	NULL
were	NULL
first	NULL
coated	NULL
with	NULL
indicated	NULL
doses	NULL
of	NULL
anti-CD3	NULL
and	NULL
subsequently	NULL
with	NULL
10	NULL
pg/ml	NULL
of	NULL
either	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
hIgG	NULL
for	NULL
2	NULL
days	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Purified	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
similarly	NULL
incubated	NULL
in	NULL
the	NULL
96-well	NULL
microplates	NULL
coated	NULL
with	NULL
40	NULL
ng/ml	NULL
anti-CD3	NULL
and	NULL
then	NULL
with	NULL
10	NULL
pg/ml	NULL
of	NULL
either	NULL
hLIGHT-Ig	NULL
or	NULL
control	NULL
hIgG	NULL
for	NULL
3	NULL
,	NULL
4	NULL
,	NULL
or	NULL
5	NULL
days	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
culture	NULL
supernatants	NULL
were	NULL
harvested	NULL
,	NULL
and	NULL
the	NULL
concentration	NULL
of	NULL
IFN-y	NULL
and	NULL
IL-4	NULL
was	NULL
assessed	NULL
by	NULL
sandwich	NULL
ELISA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
SD	NULL
of	NULL
triplicate	NULL
wells	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
cleaved	NULL
LIGHT	NULL
can	NULL
still	NULL
costimulate	NULL
T	NULL
cell	NULL
growth	NULL
.	NULL

Our	NULL
preliminary	NULL
experiments	NULL
indicate	NULL
that	NULL
LIGHT	NULL
is	NULL
detectable	NULL
as	NULL
a	NULL
soluble	NULL
form	NULL
in	NULL
culture	NULL
supernatants	NULL
of	NULL
the	NULL
cells	NULL
transfected	NULL
with	NULL
LIGHT	NULL
gene	NULL
and	NULL
that	NULL
a	NULL
metalloproteinase	NULL
inhibitor	NULL
can	NULL
decrease	NULL
a	NULL
release	NULL
of	NULL
soluble	NULL
LIGHT	NULL
(	NULL
our	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
implicate	NULL
that	NULL
matured	NULL
DCs	NULL
can	NULL
regulate	NULL
T	NULL
cell	NULL
responses	NULL
by	NULL
releasing	NULL
LIGHT	NULL
as	NULL
a	NULL
cytokine	NULL
.	NULL

DCs	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
the	NULL
most	NULL
potent	NULL
and	NULL
crucial	NULL
APCs	NULL
in	NULL
initiating	NULL
primary	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Using	NULL
HVEM-Ig	NULL
and	NULL
LTBR-Ig	NULL
fusion	NULL
proteins	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
blockade	NULL
of	NULL
LIGHT	NULL
can	NULL
inhibit	NULL
the	NULL
optimal	NULL
induction	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
responses	NULL
to	NULL
allogeneic	NULL
DCs	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
ligation	NULL
of	NULL
LIGHT	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TCR	NULL
stimulation	NULL
costimulates	NULL
naive	NULL
T	NULL
cells	NULL
to	NULL
proliferate	NULL
and	NULL
produce	NULL
IFN-y	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
extend	NULL
previous	NULL
findings	NULL
and	NULL
indicate	NULL
that	NULL
LIGHT	NULL
is	NULL
an	NULL
important	NULL
costimulator	NULL
in	NULL
DC-mediated	NULL
stimulation	NULL
of	NULL
primary	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

Costimulatory	NULL
effect	NULL
of	NULL
LIGHT	NULL
is	NULL
likely	NULL
mediated	NULL
by	NULL
its	NULL
interaction	NULL
with	NULL
HVEM	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
on	NULL
the	NULL
majority	NULL
of	NULL
PBMCs	NULL
,	NULL
including	NULL
resting	NULL
T	NULL
cells	NULL
(	NULL
14	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
HVEM	NULL
,	NULL
two	NULL
additional	NULL
receptors	NULL
,	NULL
LTBR	NULL
and	NULL
TR6	NULL
,	NULL
have	NULL
been	NULL
reported	NULL
(	NULL
11	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

However	NULL
,	NULL
LTBR	NULL
is	NULL
not	NULL
found	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
and	NULL
TR6	NULL
,	NULL
a	NULL
new	NULL
TNFR-like	NULL
molecule	NULL
,	NULL
is	NULL
found	NULL
only	NULL
as	NULL
a	NULL
decoy	NULL
receptor	NULL
without	NULL
membrane-anchor	NULL
sequence	NULL
(	NULL
32	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
with	NULL
the	NULL
fact	NULL
that	NULL
T	NULL
cell	NULL
activation	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
anti-HVEM	NULL
blocking	NULL
mAb	NULL
(	NULL
14	NULL
)	NULL
,	NULL
interaction	NULL
between	NULL
LIGHT	NULL
and	NULL
HVEM	NULL
may	NULL
be	NULL
critical	NULL
for	NULL
the	NULL
costimulatory	NULL
function	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
overexpression	NULL
of	NULL
HVEM	NULL
in	NULL
the	NULL
non-lymphoid	NULL
line	NULL
293	NULL
stimulates	NULL
TNFR-associated	NULL
factor	NULL
1	NULL
,	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
binding	NULL
and	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
signaling	NULL
pathways	NULL
(	NULL
17	NULL
,	NULL
4109	NULL
35	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
engagement	NULL
of	NULL
HVEM-expressing	NULL
U937	NULL
cells	NULL
with	NULL
soluble	NULL
LIGHT	NULL
induced	NULL
a	NULL
weak	NULL
increase	NULL
of	NULL
luciferase	NULL
activity	NULL
of	NULL
a	NULL
NF-	NULL
«	NULL
B-luciferase	NULL
reporter	NULL
gene	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Despite	NULL
these	NULL
reports	NULL
,	NULL
it	NULL
remains	NULL
unknown	NULL
whether	NULL
LIGHT	NULL
activates	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
resting	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
whether	NULL
a	NULL
combined	NULL
stimulation	NULL
of	NULL
TCR	NULL
and	NULL
LIGHT	NULL
induces	NULL
a	NULL
synergistic	NULL
effect	NULL
on	NULL
NF-KB	NULL
activation	NULL
.	NULL

We	NULL
addressed	NULL
these	NULL
issues	NULL
and	NULL
demonstrated	NULL
that	NULL
LIGHT	NULL
costimulation	NULL
induces	NULL
NF-	NULL
«	NULL
B	NULL
translocation	NULL
in	NULL
human	NULL
resting	NULL
T	NULL
cells	NULL
in	NULL
a	NULL
synergistic	NULL
manner	NULL
with	NULL
anti-CD3	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
LIGHT	NULL
,	NULL
several	NULL
members	NULL
of	NULL
the	NULL
TNFR	NULL
superfamily	NULL
,	NULL
including	NULL
4-1BB	NULL
and	NULL
OX-40	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
costimulate	NULL
T	NULL
cell	NULL
growth	NULL
and	NULL
induce	NULL
TNFR-associated	NULL
factor	NULL
binding	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
9	NULL
,	NULL
10	NULL
,	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
expression	NULL
and	NULL
function	NULL
of	NULL
these	NULL
molecules	NULL
appear	NULL
to	NULL
have	NULL
individual	NULL
characteristics	NULL
.	NULL

For	NULL
example	NULL
,	NULL
4-1BB	NULL
engagement	NULL
preferentially	NULL
activates	NULL
CD8	NULL
*	NULL
T	NULL
cells	NULL
compared	NULL
with	NULL
CD4*	NULL
T	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
,	NULL
whereas	NULL
OX-40	NULL
plays	NULL
a	NULL
predominant	NULL
role	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
because	NULL
of	NULL
its	NULL
limited	NULL
expression	NULL
on	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
(	NULL
9	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
OX-40	NULL
costimulation	NULL
polarizes	NULL
T	NULL
cells	NULL
toward	NULL
Th2-type	NULL
responses	NULL
(	NULL
37	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
LIGHT	NULL
costimulates	NULL
T	NULL
cells	NULL
to	NULL
produce	NULL
IFN-y	NULL
but	NULL
not	NULL
IL-4	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

HVEM	NULL
is	NULL
constitutively	NULL
expressed	NULL
on	NULL
resting	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
transiently	NULL
down-regulated	NULL
after	NULL
activation	NULL
(	NULL
14	NULL
)	NULL
,	NULL
which	NULL
is	NULL
a	NULL
remarkable	NULL
contrast	NULL
to	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
4-1BB	NULL
and	NULL
OX-40	NULL
on	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
the	NULL
respective	NULL
roles	NULL
of	NULL
these	NULL
costimulatory	NULL
molecules	NULL
in	NULL
the	NULL
initiation	NULL
and	NULL
expansion	NULL
phases	NULL
of	NULL
T	NULL
cell	NULL
response	NULL
.	NULL

Our	NULL
results	NULL
thus	NULL
define	NULL
a	NULL
new	NULL
costimulatory	NULL
molecule	NULL
of	NULL
the	NULL
TNF	NULL
family	NULL
that	NULL
is	NULL
potentially	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
dendritic	NULL
cell-mediated	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Acknowledgments	NULL
We	NULL
thank	NULL
the	NULL
other	NULL
scientists	NULL
of	NULL
Human	NULL
Genome	NULL
Sciences	NULL
,	NULL
Inc.	NULL
,	NULL
who	NULL
were	NULL
involved	NULL
in	NULL
the	NULL
preparation	NULL
of	NULL
human	NULL
LIGHT-Ig	NULL
fusion	NULL
protein	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
H.	NULL
Hsu	NULL
for	NULL
providing	NULL
the	NULL
human	NULL
HVEM-Ig	NULL
and	NULL
Kathy	NULL
Jensen	NULL
for	NULL
editing	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:233	NULL
.	NULL

2	NULL
.	NULL

Mueller	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
M.	NULL
K.	NULL
Jenkins	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schwartz	NULL
.	NULL

1989	NULL
.	NULL

Clonal	NULL
expansion	NULL
versus	NULL
functional	NULL
clonal	NULL
inactivation	NULL
:	NULL
a	NULL
costimulatory	NULL
signalling	NULL
pathway	NULL
determines	NULL
the	NULL
outcome	NULL
of	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
occupancy	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

7:445	NULL
.	NULL

3	NULL
.	NULL

Chen	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Ashe	NULL
,	NULL
W.	NULL
A.	NULL
Brady	NULL
,	NULL
I.	NULL
Hellstrom	NULL
,	NULL
K.	NULL
E.	NULL
Hellstrom	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
P.	NULL
McGowan	NULL
,	NULL
and	NULL
P.	NULL
S.	NULL
Linsley	NULL
.	NULL

1992	NULL
.	NULL

Costimulation	NULL
of	NULL
antitumor	NULL
immunity	NULL
by	NULL
the	NULL
B7	NULL
counterreceptor	NULL
for	NULL
the	NULL
T	NULL
lymphocyte	NULL
molecules	NULL
CD28	NULL
and	NULL
CTLA-4	NULL
.	NULL

Cell	NULL
71:1093	NULL
.	NULL

4	NULL
.	NULL

Melero	NULL
,	NULL
L	NULL
,	NULL
W.	NULL
W.	NULL
Shuford	NULL
,	NULL
S.	NULL
A.	NULL
Newby	NULL
,	NULL
A.	NULL
Aruffo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
,	NULL
K.	NULL
E.	NULL
Hellstrom	NULL
,	NULL
R.	NULL
S.	NULL
Mittler	NULL
,	NULL
and	NULL
L.	NULL
Chen	NULL
.	NULL

1997	NULL
.	NULL

Monoclonal	NULL
antibodies	NULL
against	NULL
the	NULL
4-1BB	NULL
T-cell	NULL
activation	NULL
molecule	NULL
eradicate	NULL
established	NULL
tumors	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

3:682	NULL
.	NULL

5	NULL
.	NULL

Cross	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
T.	NULL
J.	NULL
Girard	NULL
,	NULL
K.	NULL
S.	NULL
Giacoletto	NULL
,	NULL
R.	NULL
J.	NULL
Evans	NULL
,	NULL
R.	NULL
M.	NULL
Keeling	NULL
,	NULL
R.	NULL
F.	NULL
Lin	NULL
,	NULL
J.	NULL
L.	NULL
Trotter	NULL
,	NULL
and	NULL
R.	NULL
W.	NULL
Karr	NULL
.	NULL

1995	NULL
.	NULL

Long-term	NULL
inhibition	NULL
of	NULL
murine	NULL
experimental	NULL
autoimmune	NULL
encephalomyelitis	NULL
using	NULL
CTLA-4-Fc	NULL
supports	NULL
a	NULL
key	NULL
role	NULL
for	NULL
CD28	NULL
costimulation	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

95:2783	NULL
.	NULL

6	NULL
.	NULL

Blazar	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
P.	NULL
A.	NULL
Taylor	NULL
,	NULL
P.	NULL
S.	NULL
Linsley	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Vallera	NULL
.	NULL

1994	NULL
.	NULL

In	NULL
vivo	NULL
blockade	NULL
of	NULL
CD28/CTLAA4	NULL
:	NULL
B7/BB1	NULL
interaction	NULL
with	NULL
CTLA4-Ig	NULL
reduces	NULL
lethal	NULL
murine	NULL
graft-versus-host	NULL
disease	NULL
across	NULL
the	NULL
major	NULL
histocompatibility	NULL
complex	NULL
barrier	NULL
in	NULL
mice	NULL
.	NULL

Blood	NULL
83:3815	NULL
.	NULL

7	NULL
.	NULL

Banchereau	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Steinman	NULL
.	NULL

1998	NULL
.	NULL

Dendritic	NULL
cells	NULL
and	NULL
the	NULL
control	NULL
of	NULL
immunity	NULL
.	NULL

Nature	NULL
392:245	NULL
.	NULL

8	NULL
.	NULL

Smith	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
T.	NULL
Farrah	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Goodwin	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
of	NULL
cellular	NULL
and	NULL
viral	NULL
proteins	NULL
:	NULL
activation	NULL
,	NULL
costimulation	NULL
,	NULL
and	NULL
death	NULL
.	NULL

Cell	NULL
76:959	NULL
.	NULL

9	NULL
.	NULL

Godfrey	NULL
,	NULL
W.	NULL
R.	NULL
,	NULL
F.	NULL
F.	NULL
Fagnoni	NULL
,	NULL
M.	NULL
A.	NULL
Harara	NULL
,	NULL
D.	NULL
Buck	NULL
,	NULL
and	NULL
E.	NULL
G.	NULL
Engleman	NULL
.	NULL

1994	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
human	NULL
OX-40	NULL
ligand	NULL
,	NULL
a	NULL
costimulator	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
with	NULL
homology	NULL
to	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:757	NULL
.	NULL

10	NULL
.	NULL

Shuford	NULL
,	NULL
W.	NULL
W.	NULL
,	NULL
K.	NULL
Klussman	NULL
,	NULL
D.	NULL
D.	NULL
Tritchler	NULL
,	NULL
D.	NULL
T.	NULL
Loo	NULL
,	NULL
J.	NULL
Chalupny	NULL
,	NULL
A.	NULL
W.	NULL
Siadak	NULL
,	NULL
T.	NULL
J	NULL
.	NULL

Brown	NULL
,	NULL
J.	NULL
Emswiler	NULL
,	NULL
H.	NULL
Raecho	NULL
,	NULL
C.	NULL
P.	NULL
Larsen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

4-1BB	NULL
costimulatory	NULL
signals	NULL
preferentially	NULL
induce	NULL
CD8	NULL
*	NULL
T	NULL
cell	NULL
proliferation	NULL
and	NULL
lead	NULL
to	NULL
the	NULL
amplification	NULL
in	NULL
vivo	NULL
of	NULL
cytotoxic	NULL
T	NULL
cell	NULL
responses	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186:47	NULL
.	NULL

11	NULL
.	NULL

Mauri	NULL
,	NULL
D.	NULL
N.	NULL
,	NULL
R.	NULL
Ebner	NULL
,	NULL
R.	NULL
I.	NULL
Montgomery	NULL
,	NULL
K.	NULL
D.	NULL
Kochel	NULL
,	NULL
T.	NULL
C.	NULL
Cheung	NULL
,	NULL
G.-L.	NULL
Yu	NULL
,	NULL
S.	NULL
Ruben	NULL
,	NULL
M.	NULL
Murphy	NULL
,	NULL
R.	NULL
J.	NULL
Eisenberg	NULL
,	NULL
G.	NULL
H.	NULL
Cohen	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

LIGHT	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
superfamily	NULL
,	NULL
and	NULL
lymphotoxic	NULL
a	NULL
are	NULL
ligands	NULL
for	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
.	NULL

Immunity	NULL
8:21	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
4110	NULL
12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

Harrop	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
P.	NULL
C.	NULL
McDonnell	NULL
,	NULL
M.	NULL
Brigham-Burke	NULL
,	NULL
S.	NULL
D.	NULL
Lyn	NULL
,	NULL
J.	NULL
Minton	NULL
,	NULL
K.	NULL
B.	NULL
Tan	NULL
,	NULL
K.	NULL
Dede	NULL
,	NULL
J.	NULL
Spampanato	NULL
,	NULL
C.	NULL
Silverman	NULL
,	NULL
P.	NULL
Hensley	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Herpesvirus	NULL
entry	NULL
mediator	NULL
ligand	NULL
(	NULL
HVEM-L	NULL
)	NULL
,	NULL
a	NULL
novel	NULL
ligand	NULL
for	NULL
HVEM/TR2	NULL
,	NULL
stimulates	NULL
proliferation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
inhibits	NULL
HT29	NULL
cell	NULL
growth	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273:27548	NULL
.	NULL

Kwon	NULL
,	NULL
B.	NULL
S.	NULL
,	NULL
K.	NULL
B.	NULL
Tan	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
K.	NULL
O.	NULL
Oh	NULL
,	NULL
Z.	NULL
H.	NULL
Lee	NULL
,	NULL
K.	NULL
K.	NULL
Kim	NULL
,	NULL
Y.-J	NULL
.	NULL

Kim	NULL
,	NULL
S.	NULL
Wang	NULL
,	NULL
R.	NULL
Gentz	NULL
,	NULL
G.-L.	NULL
Yu	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
new	NULL
identified	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
superfamily	NULL
with	NULL
a	NULL
wide	NULL
tissue	NULL
distribution	NULL
and	NULL
involvement	NULL
in	NULL
lymphocyte	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:14272	NULL
.	NULL

Harrop	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
Reddy	NULL
,	NULL
K.	NULL
Dede	NULL
,	NULL
M.	NULL
Brigham-Burke	NULL
,	NULL
S.	NULL
Lyn	NULL
,	NULL
K.	NULL
B.	NULL
Tan	NULL
,	NULL
C.	NULL
Silverman	NULL
,	NULL
C.	NULL
Eichman	NULL
,	NULL
R.	NULL
DiPrinzio	NULL
,	NULL
J.	NULL
Spampanato	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Antibodies	NULL
to	NULL
TR2	NULL
(	NULL
herpesvirus	NULL
entry	NULL
mediator	NULL
)	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
superfamily	NULL
,	NULL
block	NULL
T	NULL
cell	NULL
proliferation	NULL
,	NULL
expression	NULL
of	NULL
activation	NULL
markers	NULL
,	NULL
and	NULL
production	NULL
of	NULL
cytokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:1786	NULL
.	NULL

Forssmann	NULL
,	NULL
U.	NULL
,	NULL
M.	NULL
B.	NULL
Delgado	NULL
,	NULL
M.	NULL
Uguccioni	NULL
,	NULL
P.	NULL
Loctscher	NULL
,	NULL
G.	NULL
Garotta	NULL
,	NULL
and	NULL
M.	NULL
Baggiolini	NULL
.	NULL

1997	NULL
.	NULL

CkB	NULL
8	NULL
,	NULL
a	NULL
novel	NULL
CC	NULL
chemokine	NULL
that	NULL
predominantly	NULL
acts	NULL
on	NULL
monocytes	NULL
.	NULL

FEBS	NULL
Lett	NULL
.	NULL

408:211	NULL
.	NULL

Coleman	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
D.	NULL
Parmelee	NULL
,	NULL
N.	NULL
R.	NULL
Thotakura	NULL
,	NULL
N.	NULL
Mguyen	NULL
,	NULL
M.	NULL
Burgin	NULL
,	NULL
S.	NULL
Gentz	NULL
,	NULL
and	NULL
R.	NULL
Gentz	NULL
.	NULL

1997	NULL
.	NULL

Production	NULL
and	NULL
purification	NULL
of	NULL
novel	NULL
secreted	NULL
human	NULL
proteins	NULL
.	NULL

Gene	NULL
190:163	NULL
.	NULL

Hsu	NULL
,	NULL
H.	NULL
,	NULL
I.	NULL
Solovyev	NULL
,	NULL
A.	NULL
Colombero	NULL
,	NULL
R.	NULL
Elliott	NULL
,	NULL
M.	NULL
Kelley	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Boyle	NULL
.	NULL

1997	NULL
.	NULL

ATAR	NULL
,	NULL
a	NULL
novel	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
member	NULL
,	NULL
signals	NULL
through	NULL
TRAF2	NULL
and	NULL
TRAFS	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:13471	NULL
.	NULL

Zhai	NULL
,	NULL
Y.	NULL
,	NULL
R.	NULL
Guo	NULL
,	NULL
T.-L.	NULL
Hsu	NULL
,	NULL
G.-L.	NULL
Yu	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
B.	NULL
S.	NULL
Kwon	NULL
,	NULL
G.-W.	NULL
Jiang	NULL
,	NULL
J.	NULL
Lu	NULL
,	NULL
J.	NULL
Tan	NULL
,	NULL
M.	NULL
Ugustus	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

LIGHT	NULL
,	NULL
a	NULL
novel	NULL
ligand	NULL
for	NULL
lymphotoxin	NULL
$	NULL
receptor	NULL
and	NULL
TR2/HVEM	NULL
induces	NULL
apoptosis	NULL
and	NULL
suppresses	NULL
in	NULL
vivo	NULL
tumor	NULL
formation	NULL
via	NULL
gene	NULL
transfer	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

102:1142	NULL
.	NULL

Linsley	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
W.	NULL
Brady	NULL
,	NULL
M.	NULL
Urnes	NULL
,	NULL
L.	NULL
S.	NULL
Grosmaire	NULL
,	NULL
N.	NULL
K.	NULL
Damle	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Ledbetter	NULL
.	NULL

1991	NULL
.	NULL

CTLA-4	NULL
is	NULL
a	NULL
second	NULL
receptor	NULL
for	NULL
the	NULL
B	NULL
cell	NULL
activation	NULL
antigen	NULL
B7	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:561	NULL
.	NULL

Tamada	NULL
,	NULL
K.	NULL
,	NULL
K.	NULL
Shimozaki	NULL
,	NULL
A.	NULL
I.	NULL
Chapoval	NULL
,	NULL
G.	NULL
Zhu	NULL
,	NULL
G.	NULL
Sica	NULL
,	NULL
D.	NULL
Flies	NULL
,	NULL
T.	NULL
Boone	NULL
,	NULL
H.	NULL
Hsu	NULL
,	NULL
Y.	NULL
Fu	NULL
,	NULL
S.	NULL
Nagata	NULL
,	NULL
et	NULL
al	NULL
.	NULL

2000	NULL
.	NULL

Modulation	NULL
of	NULL
T-cell-mediated	NULL
immunity	NULL
in	NULL
tumor	NULL
and	NULL
graft-versus-host	NULL
disease	NULL
models	NULL
through	NULL
the	NULL
LIGHT	NULL
co-stimulatory	NULL
pathway	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

6:283	NULL
.	NULL

Romani	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Gruner	NULL
,	NULL
D.	NULL
Brang	NULL
,	NULL
E.	NULL
Kampgen	NULL
,	NULL
A.	NULL
Lenz	NULL
,	NULL
and	NULL
B.	NULL
Trockenbacher	NULL
.	NULL

1994	NULL
.	NULL

Proliferating	NULL
dendritic	NULL
cell	NULL
progenitors	NULL
in	NULL
human	NULL
blood	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:83	NULL
.	NULL

Thomas	NULL
,	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Lipsky	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
and	NULL
characterization	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
dendritic	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

150:821	NULL
.	NULL

Orita	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Shimozaki	NULL
,	NULL
H.	NULL
Murakami	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1997	NULL
.	NULL

Binding	NULL
of	NULL
NF-Y	NULL
transcription	NULL
factor	NULL
to	NULL
one	NULL
of	NULL
the	NULL
cis-elements	NULL
in	NULL
the	NULL
myeloperoxidase	NULL
gene	NULL
promoter	NULL
that	NULL
responds	NULL
to	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
;	NULL
23216	NULL
.	NULL

Murai	NULL
,	NULL
K.	NULL
,	NULL
H.	NULL
Murakami	NULL
,	NULL
and	NULL
S.	NULL
Nagata	NULL
.	NULL

1998	NULL
.	NULL

Myeloid-specific	NULL
transcriptional	NULL
activation	NULL
by	NULL
murine	NULL
myeloid	NULL
zinc-finger	NULL
protein	NULL
2	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
95:3461	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

COSTIMULATORY	NULL
LIGAND	NULL
LIGHT	NULL
ON	NULL
HUMAN	NULL
DCs	NULL
Caux	NULL
,	NULL
C.	NULL
,	NULL
C.	NULL
Massacrier	NULL
,	NULL
B.	NULL
Vanbervliet	NULL
,	NULL
B.	NULL
Dubois	NULL
,	NULL
C.	NULL
Van	NULL
Kooten	NULL
,	NULL
I.	NULL
Durand	NULL
,	NULL
and	NULL
J.	NULL
Banchereau	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
human	NULL
dendritic	NULL
cells	NULL
through	NULL
CD40	NULL
cross-linking	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:1263	NULL
.	NULL

Cella	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Scheidegger	NULL
,	NULL
K.	NULL
Palmer-Lehmann	NULL
,	NULL
P.	NULL
Lane	NULL
,	NULL
A.	NULL
Lanzavecchia	NULL
,	NULL
and	NULL
G.	NULL
Alber	NULL
.	NULL

1996	NULL
.	NULL

Ligation	NULL
of	NULL
CD40	NULL
on	NULL
dendritic	NULL
cells	NULL
triggers	NULL
production	NULL
of	NULL
high	NULL
levels	NULL
of	NULL
interleukin-12	NULL
and	NULL
enhances	NULL
T	NULL
cell	NULL
stimulatory	NULL
capacity	NULL
:	NULL
T-T	NULL
help	NULL
via	NULL
APC	NULL
activation	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

184:747	NULL
.	NULL

O'Doherty	NULL
,	NULL
U.	NULL
,	NULL
R.	NULL
M.	NULL
Steinman	NULL
,	NULL
M.	NULL
Peng	NULL
,	NULL
P.	NULL
U.	NULL
Cameron	NULL
,	NULL
S.	NULL
Gezelter	NULL
,	NULL
I.	NULL
Kopeloff	NULL
,	NULL
W.	NULL
J.	NULL
Swiggard	NULL
,	NULL
M.	NULL
Pope	NULL
,	NULL
and	NULL
N.	NULL
Bhardwaj	NULL
.	NULL

1993	NULL
.	NULL

Dendritic	NULL
cells	NULL
freshly	NULL
isolated	NULL
from	NULL
human	NULL
blood	NULL
express	NULL
CD4	NULL
and	NULL
mature	NULL
into	NULL
typical	NULL
immu-nostimulatory	NULL
dendritic	NULL
cells	NULL
after	NULL
culture	NULL
in	NULL
monocyte-conditioned	NULL
medium	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1067	NULL
.	NULL

Kohrgruber	NULL
,	NULL
N.	NULL
,	NULL
N.	NULL
Halanck	NULL
,	NULL
M.	NULL
Groger	NULL
,	NULL
D.	NULL
Winter	NULL
,	NULL
K.	NULL
Rappersberger	NULL
,	NULL
M.	NULL
Schmitt-Egenolf	NULL
,	NULL
G.	NULL
Stingl	NULL
,	NULL
and	NULL
D.	NULL
Maurer	NULL
.	NULL

1999	NULL
.	NULL

Survival	NULL
,	NULL
maturation	NULL
,	NULL
and	NULL
function	NULL
of	NULL
CD11c~	NULL
and	NULL
peripheral	NULL
blood	NULL
dendritic	NULL
cells	NULL
are	NULL
differen-tially	NULL
regulated	NULL
by	NULL
cytokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163:3250	NULL
.	NULL

Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Jr.	NULL
1996	NULL
.	NULL

The	NULL
NF-KB	NULL
and	NULL
IB	NULL
proteins	NULL
:	NULL
new	NULL
discoveries	NULL
and	NULL
insights	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:649	NULL
.	NULL

Gearing	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
P.	NULL
Beckett	NULL
,	NULL
M.	NULL
Christodoulou	NULL
,	NULL
M.	NULL
Churchill	NULL
,	NULL
J.	NULL
Clements	NULL
,	NULL
A.	NULL
H.	NULL
Davidson	NULL
,	NULL
A.	NULL
H.	NULL
Drummond	NULL
,	NULL
W.	NULL
A.	NULL
Galloway	NULL
,	NULL
R.	NULL
Gilbert	NULL
,	NULL
J.	NULL
L.	NULL
Gordon	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Processing	NULL
of	NULL
tumour	NULL
necrosis	NULL
factor-a	NULL
precursor	NULL
by	NULL
metalloproteinases	NULL
.	NULL

Nature	NULL
370:555	NULL
.	NULL

Kayagaki	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
Kawasaki	NULL
,	NULL
T.	NULL
Ebata	NULL
,	NULL
H.	NULL
Ohmoto	NULL
,	NULL
S.	NULL
Ikeda	NULL
,	NULL
S.	NULL
Inoue	NULL
,	NULL
K.	NULL
Yoshino	NULL
,	NULL
K.	NULL
Okumura	NULL
,	NULL
and	NULL
H.	NULL
Yagita	NULL
.	NULL

1995	NULL
.	NULL

Metalloproteinase-mediated	NULL
release	NULL
of	NULL
human	NULL
Fas	NULL
ligand	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

182:1777	NULL
.	NULL

Pitti	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
S.	NULL
A.	NULL
Marsters	NULL
,	NULL
D.	NULL
A.	NULL
Lawrence	NULL
,	NULL
M.	NULL
Roy	NULL
,	NULL
F.	NULL
C.	NULL
Kischkel	NULL
,	NULL
P.	NULL
Dowd	NULL
,	NULL
A.	NULL
Huang	NULL
,	NULL
C.	NULL
J.	NULL
Donahue	NULL
,	NULL
S.	NULL
W.	NULL
Sherwood	NULL
,	NULL
D.	NULL
T.	NULL
Baldwin	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1998	NULL
.	NULL

Genomic	NULL
amplification	NULL
of	NULL
a	NULL
decoy	NULL
receptor	NULL
for	NULL
Fas	NULL
ligand	NULL
in	NULL
lung	NULL
and	NULL
colon	NULL
cancer	NULL
.	NULL

Nature	NULL
396:699	NULL
.	NULL

Yu	NULL
,	NULL
K.	NULL
Y.	NULL
,	NULL
B.	NULL
Kwon	NULL
,	NULL
J.	NULL
Ni	NULL
,	NULL
Y.	NULL
Zhai	NULL
,	NULL
R.	NULL
Ebner	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Kwon	NULL
.	NULL

1999	NULL
.	NULL

A	NULL
newly	NULL
identified	NULL
member	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
superfamily	NULL
(	NULL
TR6	NULL
)	NULL
suppresses	NULL
LIGHT-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274:13733	NULL
.	NULL

Ware	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
T.	NULL
L.	NULL
VanArsdale	NULL
,	NULL
P.	NULL
D.	NULL
Crowe	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Browning	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
ligands	NULL
and	NULL
receptors	NULL
of	NULL
the	NULL
lymphotoxin	NULL
system	NULL
.	NULL

Curr	NULL
.	NULL

Top	NULL
.	NULL

Microbiol	NULL
.	NULL

Immunol	NULL
.	NULL

198:175	NULL
.	NULL

Marsters	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
T.	NULL
M.	NULL
Ayres	NULL
,	NULL
M.	NULL
Skubaich	NULL
,	NULL
C.	NULL
L.	NULL
Gray	NULL
,	NULL
M.	NULL
Rothe	NULL
,	NULL
and	NULL
A.	NULL
Ashkenazi	NULL
.	NULL

1997	NULL
.	NULL

Herpesvirus	NULL
entry	NULL
mediator	NULL
,	NULL
a	NULL
member	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
(	NULL
TNFR	NULL
)	NULL
family	NULL
,	NULL
interacts	NULL
with	NULL
members	NULL
of	NULL
the	NULL
TNFR-associated	NULL
factor	NULL
family	NULL
and	NULL
activates	NULL
the	NULL
transcription	NULL
factors	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272:14029	NULL
.	NULL

Watts	NULL
,	NULL
T.	NULL
H.	NULL
,	NULL
and	NULL
M.	NULL
A.	NULL
DeBenedette	NULL
.	NULL

1999	NULL
.	NULL

T	NULL
cell	NULL
co-stimulatory	NULL
molecules	NULL
other	NULL
than	NULL
CD28	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

11:286	NULL
.	NULL

Flynn	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
M.	NULL
Toellner	NULL
,	NULL
C.	NULL
Raykundalia	NULL
,	NULL
M.	NULL
Goodall	NULL
,	NULL
and	NULL
P.	NULL
Lane	NULL
.	NULL

1998	NULL
.	NULL

CD4	NULL
T	NULL
cell	NULL
cytokine	NULL
differentiation	NULL
:	NULL
the	NULL
B	NULL
cell	NULL
activation	NULL
molecule	NULL
,	NULL
OX40	NULL
ligand	NULL
,	NULL
instructs	NULL
CD4	NULL
T	NULL
cells	NULL
to	NULL
express	NULL
interleukin	NULL
4	NULL
and	NULL
upregulates	NULL
expression	NULL
of	NULL
the	NULL
chemokine	NULL
receptor	NULL
,	NULL
Blr-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188:297	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

